We have been working alongside the startup 4D Lifetec since their foundation and are pleased to congratulate the team today. The young company, which has successfully developed a proprietary liquid biopsy assay for early cancer detection to clinical application, has announced a collaboration with VolitionRX.

The combination of the two companies' assays is expected to result in a completely novel, high-impact diagnostic model for early cancer detection based on liquid biopsy.

Read the detailed information here online or download the pdf.